Diabetes Research
Data on AIR Inhaled Insulin System presented at American Diabetes Association meeting
Published in Gene Therapy Weekly, July 13th, 2006
Eli Lilly and Company (LLY) and Alkermes, Inc. (ALKS) reported new study results of the companies' investigational AIR Inhaled Insulin System(1) (AIR insulin system), including the first published analysis of the effect of chronic obstructive pulmonary disease (COPD) on inhaled insulin absorption and action; the importance to patients of simple, patient-directed training of an inhaled insulin system; and dosing flexibility with the AIR insulin system.
These study findings were presented at the American Diabetes Association's (ADA) 66th Annual Scientific Sessions. The AIR insulin system is currently in Phase 3 clinical development by Lilly and Alkermes, and is being...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-07-13)
More Articles from Gene Therapy Weekly
- Gene Knockdown
Gene knockdown constructs generated with convergent H1 and U6 promoters - Hypertension
Genetic hypertension is ameliorated by specific kinase suppression - Orthopedics
Regulation of Runx2-stimulated osteogenesis can be induced - RNA Interference
Drosophila RNAi screen identifies specific kinases as nuclear factor regulators - RNA Research
Intracellular-diced dsRNA silences HCV RNA and overcomes genotypic variation - Apoptosis
Apoptosis detected using functionalized bimodal lipid-based contrast agents - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
